Methods of treating various cancers using an AXL/cMET inhibitor in combination with other agents
US10028956B2 · kind B2 · utility
0Cited by
2References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 31, 2014 |
| Grant date | Jul 24, 2018 |
| Priority date | — |
| Expiry date | Jul 31, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/541
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This application describes the use of the compound (I) or a salt thereof, either alone or in combination with other therapeutically active agents, for the treatment of particular cancers, including any solid or hematological cancer in which AXL or c-Met is over-expressed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.